Results 31 to 40 of about 26,297 (225)
Acta chirurgica Iugoslavica, 2008 Diverticular disease produces a wide range of clinical presentations varying from minimal clinical discomfort to life-threatening complications. Often there is a considerable discrepancy between clinical, radiologic, endoscopic and pathologic findings. Diverticulosis is a quite common disease affecting about 2/3 of people in the Western world over the ...
openaire +3 more sources
JEADV Clinical Practice, EarlyView.ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson +12 more
wiley +1 more source
Retrospective Review on Safety and Efficacy of Combination Biologic Therapy for Psoriasis
Australasian Journal of Dermatology, EarlyView.ABSTRACT Background There is limited data on the use of dual or combination biologic therapy in dermatological patients, particularly in psoriasis or with other coexisting dermatological conditions. However, this may be necessary for a small proportion of patients.
Nicole Kah Mun Yoong +2 more
wiley +1 more source
Management of Diverticulitis and Prevention of Recurrence [PDF]
European Medical Journal Gastroenterology, 2015 Acute diverticulitis is an acute inflammation of colonic diverticulae that is associated with an episode of severe, prolonged, lower abdominal pain (usually on the left side), changes in bowel movements, low-grade fever, and leukocytosis.
Paolo Andreozzi +3 more
doaj
British Journal of Haematology, EarlyView.In this population‐based study the relapse rates were remarkably low in patients reaching day 79 with active treatment, challenging the widely accepted belief that ALL is difficult to cure in the elderly. Summary Population data have shown that the prognosis for elderly patients with acute lymphoblastic leukaemia (ALL) is poor, even in the modern era ...
P. Quist‐Paulsen +8 more
wiley +1 more source
Medicina, 2021 Background and Objectives: The incidence of diverticulitis is increasing in western countries. Complicated diverticulitis is defined as diverticulitis associated with localized or generalized perforation, localized or distant abscess, fistula, stricture ...
Antonietta Lamazza +7 more
doaj +1 more source
Clinical and Experimental Neuroimmunology, EarlyView.ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa +2 more
wiley +1 more source
Acute Diverticulitis in the Young: The Same Disease in a Different Patient
Gastroenterology Research and Practice, 2013 Background. Natural history and risk factors for diverticulitis in young patients are still debatable. This study aimed to assess whether difference exists in patients aged 50 and younger when compared to older patients and to identify risk factors for ...
Adolfo Pisanu +4 more
doaj +1 more source
International Journal of Infectious Diseases, 2022 Objectives: Despite the availability of international guidelines advocating shorter treatment durations, nonadherence to them is common. We assessed duration of antibiotic treatment for diverticulitis, complicated urinary tract infection (UTI), and ...
Nicolas Eduard Frei +3 more
doaj +1 more source
Headache: The Journal of Head and Face Pain, EarlyView.Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow +3 more
wiley +1 more source